| SANTANDER AM LATIN AMERICAN EQUITY OPPORTUNITIES F CAP | RVI LATINOAMÉRICA | 51,88% | · | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I EUR CAP | RVI EMERGENTES | 51,87% | 59,65% | · | · |
| ROBECO ASIA-PACIFIC EQUITIES D EUR | RVI ASIA | 51,84% | 68,84% | 63,52% | 154,28% |
| ISHARES MSCI EM EX-CHINA UCITS ETF USD (ACC) | RVI EMERGENTES | 51,83% | 66,60% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO R EUR CAP | RVI EMERGENTES | 51,82% | 59,43% | · | · |
| DWS INVEST LATIN AMERICAN EQUITIES LC | RVI LATINOAMÉRICA | 51,79% | 54,95% | 73,70% | 206,56% |
| SCHRODER ISF LATIN AMERICAN C ACC EUR | RVI LATINOAMÉRICA | 51,76% | 49,75% | 69,35% | 137,76% |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | BIOTECNOLOGÍA | 51,76% | 24,49% | 24,57% | 86,47% |
| SCHRODER ISF GLOBAL EMERGING MARKET OPPORTUNITIES IZ ACC USD | RVI EMERGENTES | 51,75% | 54,70% | 30,54% | · |
| TEMPLETON EMERGING MARKETS W (ACC) USD | RVI EMERGENTES | 51,74% | 67,81% | 35,39% | 169,56% |
